 |
Articles: Drug/Product Approvals |
Prior Articles
ONGLYZA (saxagliptin) Receives Marketing Authorisation In Europe For The Treatment Of Type 2 Diabetes
Bristol Myers-Squibb Company, 10/06/09
Free full text
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Free full text
APP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
American Pharmaceutical Partners, 10/02/09
Free full text
InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP-T™ Technology for production of recombinant proteins
b3c newswire, 10/02/09 New Drug Approval
American Journal of Nursing, 10/01/09 Pandemic (H1N1) 2009 Influenza Update: GSKs H1N1 Pandemrix vaccine receives European Commission Approval
GlaxoSmithKline, 10/01/09
Free full text
Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09 ClikSTAR a new reusable insulin pen for use with Lantus and Apidra approved in EU and Canada
Sanofi-aventis, 10/01/09
Free full text
United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
BioMarin, 10/01/09
Free full text
BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 2009
Cell Genesys, 10/01/09
Free full text
Covidien Receives FDA Clearance for its Mallinckrodt(TM) TaperGuard(TM) Evac Endotracheal Tube
Covidien, 10/01/09 Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 09/30/09
Free full text
Survey: Physicians confused about off-label drug use
Medical Economics, 09/29/09 Novartis A(H1N1) Pandemic Influenza vaccine Focetria receives positive opinion from CHMP
Novartis, 09/28/09
Free full text
Merck Statement About JANUVIA™ (sitagliptin) and JANUMET™
Merck & Co., 09/28/09
Free full text
Pandemic (H1N1) 2009 Influenza Update: GSKs H1N1 Pandemrix vaccine receives positive opinion from European Regulators
GlaxoSmithKline, 09/28/09
Free full text
Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN(TM) for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09
Free full text
Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young Children
Wyeth, 09/28/09
Free full text
Allos Therapeutics' FOLOTYN(TM) First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09
Free full text
FDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets
Covidien, 09/28/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
